Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cognium is a proprietary Ayurvedic formulation developed by Charak Pharmaceuticals, available in both tablet and syrup forms. It is designed to preserve and enhance cognitive functions, including memory, concentration, and attention span. Cognium contains a synergistic blend of traditional Ayurvedic herbs, including Brahmi (*Centella asiatica*), Jala Brahmi (*Bacopa monnieri*), Shankhapushpi (*Convolvulus pluricaulis*), Ashwagandha (*Withania somnifera*), Jyotishmati (*Celastrus paniculatus*), and Arjuna (*Terminalia arjuna*). These herbal ingredients work together to improve blood circulation to the central nervous system, protect neurons from oxidative stress, and act as adaptogens to mitigate mental fatigue and anxiety. It is commonly used by students, professionals, and individuals experiencing age-related cognitive decline or attention deficit hyperactivity disorder (ADHD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cognium.